Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Epstein-Barr virus-recent advances.

Macsween KF, Crawford DH.

Lancet Infect Dis. 2003 Mar;3(3):131-40. Review.

PMID:
12614729
2.

Infectious mononucleosis and Epstein-Barr virus.

Vetsika EK, Callan M.

Expert Rev Mol Med. 2004 Nov 5;6(23):1-16. Review.

PMID:
15541197
3.

Spectrum of Epstein-Barr virus-associated diseases.

Kutok JL, Wang F.

Annu Rev Pathol. 2006;1:375-404. Review.

PMID:
18039120
4.

Epstein-Barr virus-associated lymphoproliferative disorders.

Rezk SA, Weiss LM.

Hum Pathol. 2007 Sep;38(9):1293-304. Review.

PMID:
17707260
5.
6.

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

Niller HH, Wolf H, Minarovits J.

Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Review.

PMID:
18432410
7.

Persistence of the Epstein-Barr virus and the origins of associated lymphomas.

Thorley-Lawson DA, Gross A.

N Engl J Med. 2004 Mar 25;350(13):1328-37. Review. No abstract available.

PMID:
15044644
8.

Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.

Kalla M, Hammerschmidt W.

Eur J Cell Biol. 2012 Jan;91(1):65-9. doi: 10.1016/j.ejcb.2011.01.014. Epub 2011 Mar 29. Review.

PMID:
21450364
9.

Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.

Cohen JI.

Semin Hematol. 2003 Apr;40(2):116-23. Review.

PMID:
12704588
10.

B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.

Dolcetti R.

Autoimmun Rev. 2007 Dec;7(2):96-101. Epub 2007 Mar 26. Review.

PMID:
18035317
11.

Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality.

Thorley-Lawson DA, Duca KA, Shapiro M.

Trends Immunol. 2008 Apr;29(4):195-201. doi: 10.1016/j.it.2008.01.006. Epub 2008 Mar 6. Review.

PMID:
18328785
12.

Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions.

Klein E, Kis LL, Klein G.

Oncogene. 2007 Feb 26;26(9):1297-305. Review.

PMID:
17322915
13.

The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease.

Hsieh WS, Lemas MV, Ambinder RF.

Transpl Infect Dis. 1999 Sep;1(3):204-12. Review.

PMID:
11428990
14.

Epstein-Barr virus-associated lymphoproliferative disorders.

Grywalska E, Markowicz J, Grabarczyk P, Pasiarski M, Roliński J.

Postepy Hig Med Dosw (Online). 2013 May 24;67:481-90. Review.

15.

[Hodgkin's disease and Epstein-Barr virus].

Depil S, Moralès O, Auriault C.

Ann Biol Clin (Paris). 2004 Nov-Dec;62(6):639-48. Review. French.

PMID:
15563422
16.

Epstein-Barr virus-associated lymphomas.

Gandhi MK.

Expert Rev Anti Infect Ther. 2006 Feb;4(1):77-89. Review.

PMID:
16441211
17.

The ecology and pathology of Epstein-Barr virus.

Schmidt CW, Misko IS.

Immunol Cell Biol. 1995 Dec;73(6):489-504. Review.

18.

[Epstein-barr virus gene expression in latent infection and B-lymphocyte growth transformation].

Harada S.

Uirusu. 2002 Jun;52(1):129-34. Review. Japanese. No abstract available.

19.

The pathogenesis of Epstein-Barr virus persistent infection.

Thorley-Lawson DA, Hawkins JB, Tracy SI, Shapiro M.

Curr Opin Virol. 2013 Jun;3(3):227-32. doi: 10.1016/j.coviro.2013.04.005. Epub 2013 May 15. Review.

20.

The ins and outs of EBV infection.

Faulkner GC, Krajewski AS, Crawford DH.

Trends Microbiol. 2000 Apr;8(4):185-9. Review.

PMID:
10754578
Items per page

Supplemental Content

Write to the Help Desk